Schedule 13G ownership disclosure
Aurinia Pharmaceuticals Inc
Security class unavailable · CUSIP: 05156V102
Event date: 2022-10-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.5300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001172661-22-002260
- Form type
- SC 13G
- Filer
- Aurinia Pharmaceuticals Inc.
- CIK
- CIK 1600620
- Filed
- Oct 28, 2022
- Reporting period
- Oct 18, 2022
- Description
- Schedule 13G beneficial ownership